共 128 条
[1]
Leise MD(2014)Drug-induced liver injury Mayo Clin. Proc. 89 95-106
[2]
Poterucha JJ(2008)Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 135 1924-1934
[3]
Talwalkar JA(2012)A prospective nationwide study of drug-induced liver injury in Korea Am. J. Gastroenterol. 107 1380-1387
[4]
Chalasani N(2013)Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients Eur. J. Gastroenterol. Hepatol. 25 825-829
[5]
Suk KT(2014)Overview of Drug-Induced Liver Injury in China Clin. Liver Dis. 4 26-29
[6]
Zhou Y(2007)Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine Prog. Neurobiol. 82 1-10
[7]
Yang L(2010)Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis Planta Med. 76 1447-1453
[8]
Liao Z(2005)Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine Invest. New Drugs 23 547-553
[9]
He X(2004)Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis Toxicology 201 31-38
[10]
Guo H(2012)The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells PLoS One 7 e52536-238